Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank33
3Y CAGR-20.3%
5Y CAGR-31.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-20.3%/yr
Annual compound
5Y CAGR
-31.9%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.43 | +30.4% |
| 2023 | 1.10 | +90.4% |
| 2022 | 0.58 | -79.6% |
| 2021 | 2.83 | -65.6% |
| 2020 | 8.24 | -15.9% |
| 2019 | 9.79 | -64.2% |
| 2018 | 27.38 | - |